Patheon to Highlight Softgel Technologies at FCE Pharma

Patheon Inc. , the pharmaceutical services business owned by DPx Holdings, will introduce the company’s capabilities at FCE Pharma in São Paulo, Brazil, May 12-14, 2014.

Patheon executives as well as technical and scientific experts will attend FCE Pharma and will be available to discuss Patheon’s capabilities, while highlighting the company’s softgel technologies. Patheon is a world leader in softgel technologies, manufacturing and can customize alkali, acidic and non-animal gelatin shells for liquids, suspensions, semi-solids of any viscosity and solid fill materials. Representatives can be found in Aisle C6, Stand C45 for the duration of the conference. To schedule a meeting in advance, please email events@patheon.com .

FCE Pharma focuses on the production chain in the pharmaceutical sector, especially the phases of manufacture, supply and distribution of products and services, including: raw materials, chemistry, packaging, labeling, machines and equipment, services for the pharmaceutical industry, pharmaceutical engineering, processes, quality control, contamination control, transport and logistics, outsourcing and consultancy, laboratory and analytical equipment, process equipment, valves, sprays, industrial automation, technology and printing services for the pharmaceutical industry.

For more information on upcoming events, visit http://www.patheon.com/Knowledge-Library/Events.aspx .

Patheon is a leading provider of contract development and commercial manufacturing (CDMO) services to the global pharmaceutical industry for a full array of solid and sterile dosage forms. Patheon, a DPX business unit, encompasses the combined CMO capabilities and pharmaceutical product development services (PDS), as well as the Biosolutions and Biologics (BIO) business. For more information visit http://www.patheon.com .

About Us

Patheon® is a leading provider of contract development and commercial manufacturing (CDMO) services to the global pharmaceutical industry for a full array of solid and sterile dosage forms, including large and small molecule API. Patheon, a business unit of DPx Holdings B.V., encompasses the combined commercial manufacturing capabilities and pharmaceutical product development services, as well as offers a full array of biologic services and pharmaceutical active pharmaceutical ingredients (API) development. Patheon is #1 in product development services, #2 in commercial scale product manufacturing and is #1 in quality. For more information, visit http://www.patheon.com.